

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.90130802 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.72586471 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72586471 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 5.47964063 |
| 5 | microglial cell activation (GO:0001774) | 5.30810434 |
| 6 | cellular extravasation (GO:0045123) | 4.97565756 |
| 7 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.74118838 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47550080 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.47550080 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47550080 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47550080 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47550080 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.47550080 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.41176928 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.37017452 |
| 16 | detection of other organism (GO:0098543) | 4.30901696 |
| 17 | macrophage activation (GO:0042116) | 4.30873094 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30418084 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.24345982 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21903013 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11029375 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 4.08402742 |
| 23 | negative regulation of T cell mediated immunity (GO:0002710) | 4.04521186 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.98407484 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94036269 |
| 26 | detection of biotic stimulus (GO:0009595) | 3.91857156 |
| 27 | histone H3-K4 trimethylation (GO:0080182) | 3.91731132 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.85621116 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.84843404 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.81125932 |
| 31 | positive thymic T cell selection (GO:0045059) | 3.79011978 |
| 32 | germinal center formation (GO:0002467) | 3.77977516 |
| 33 | response to interleukin-15 (GO:0070672) | 3.77637691 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 3.76896759 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.72437630 |
| 36 | activated T cell proliferation (GO:0050798) | 3.69429699 |
| 37 | detection of bacterium (GO:0016045) | 3.66302048 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 3.61749499 |
| 39 | neutrophil activation (GO:0042119) | 3.57984850 |
| 40 | B cell homeostasis (GO:0001782) | 3.55805684 |
| 41 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52335032 |
| 42 | I-kappaB phosphorylation (GO:0007252) | 3.49721819 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.49006336 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.48795981 |
| 45 | positive regulation of granulocyte differentiation (GO:0030854) | 3.43386644 |
| 46 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.40580028 |
| 47 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.40073654 |
| 48 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.40053994 |
| 49 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33498187 |
| 50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.32818005 |
| 51 | granulocyte activation (GO:0036230) | 3.31582319 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31180324 |
| 53 | * myeloid leukocyte mediated immunity (GO:0002444) | 3.26780880 |
| 54 | leukocyte aggregation (GO:0070486) | 3.24502348 |
| 55 | positive T cell selection (GO:0043368) | 3.23747813 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23740187 |
| 57 | response to host immune response (GO:0052572) | 3.23740187 |
| 58 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.23464236 |
| 59 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22664008 |
| 60 | macroautophagy (GO:0016236) | 3.20688357 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.20568870 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.19919720 |
| 63 | modulation by symbiont of host cellular process (GO:0044068) | 3.19048723 |
| 64 | response to peptidoglycan (GO:0032494) | 3.17352947 |
| 65 | negative regulation of granulocyte differentiation (GO:0030853) | 3.13958154 |
| 66 | T cell migration (GO:0072678) | 3.12566106 |
| 67 | interferon-gamma production (GO:0032609) | 3.10924455 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10921413 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.10097150 |
| 70 | positive regulation of mast cell activation (GO:0033005) | 3.09267614 |
| 71 | negative regulation of B cell proliferation (GO:0030889) | 3.08737405 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.05441731 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04753570 |
| 74 | negative regulation of adaptive immune response (GO:0002820) | 3.03902911 |
| 75 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01401724 |
| 76 | negative T cell selection (GO:0043383) | 3.00671585 |
| 77 | negative regulation of lipid storage (GO:0010888) | 2.99411538 |
| 78 | response to host (GO:0075136) | 2.98783925 |
| 79 | response to host defenses (GO:0052200) | 2.98783925 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98783925 |
| 81 | dendritic cell migration (GO:0036336) | 2.97020328 |
| 82 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.92589981 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.91569914 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91523133 |
| 85 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91523133 |
| 86 | cellular response to ethanol (GO:0071361) | 2.86860750 |
| 87 | negative regulation of interleukin-1 production (GO:0032692) | 2.86789172 |
| 88 | * neutrophil mediated immunity (GO:0002446) | 2.85250332 |
| 89 | myeloid leukocyte activation (GO:0002274) | 2.82567950 |
| 90 | regulation of necroptotic process (GO:0060544) | 2.82003777 |
| 91 | negative regulation of interleukin-17 production (GO:0032700) | 2.81404258 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 2.78219621 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.78126945 |
| 94 | mature B cell differentiation (GO:0002335) | 2.77785900 |
| 95 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.77579158 |
| 96 | B cell proliferation (GO:0042100) | 2.76004618 |
| 97 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.74987780 |
| 98 | negative regulation of B cell mediated immunity (GO:0002713) | 2.74987780 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.74632027 |
| 100 | lipoprotein transport (GO:0042953) | 2.74126338 |
| 101 | T cell proliferation (GO:0042098) | 2.73861338 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.73647362 |
| 103 | positive regulation of cholesterol efflux (GO:0010875) | 2.72071074 |
| 104 | positive regulation of interferon-alpha production (GO:0032727) | 2.72069275 |
| 105 | histone H3-K4 methylation (GO:0051568) | 2.71830871 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.70971722 |
| 107 | G-protein coupled receptor internalization (GO:0002031) | 2.68239347 |
| 108 | developmental pigmentation (GO:0048066) | 2.67914008 |
| 109 | cytokine secretion (GO:0050663) | 2.67867603 |
| 110 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.65030967 |
| 111 | respiratory burst (GO:0045730) | 2.62509261 |
| 112 | positive regulation of p38MAPK cascade (GO:1900745) | 2.60823413 |
| 113 | regulation of germinal center formation (GO:0002634) | 2.59362007 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.58886029 |
| 115 | regulation of integrin activation (GO:0033623) | 2.56766242 |
| 116 | positive regulation of humoral immune response (GO:0002922) | 2.54274960 |
| 117 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.54082972 |
| 118 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.54082972 |
| 119 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.54082972 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53649518 |
| 121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52288194 |
| 122 | pinocytosis (GO:0006907) | 2.52106220 |
| 123 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.51747915 |
| 124 | Golgi to endosome transport (GO:0006895) | 2.51727020 |
| 125 | regulation of mast cell degranulation (GO:0043304) | 2.51604026 |
| 126 | regulation of leukocyte degranulation (GO:0043300) | 2.51530066 |
| 127 | T cell selection (GO:0045058) | 2.51451164 |
| 128 | peptidyl-lysine trimethylation (GO:0018023) | 2.50441143 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.49872038 |
| 130 | regulation of protein polyubiquitination (GO:1902914) | 2.47612067 |
| 131 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.46918100 |
| 132 | thymic T cell selection (GO:0045061) | 2.46254517 |
| 133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.44884692 |
| 134 | lymphocyte homeostasis (GO:0002260) | 2.43468165 |
| 135 | histone H3-K36 demethylation (GO:0070544) | 2.43090213 |
| 136 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.42699130 |
| 137 | negative regulation of interleukin-6 production (GO:0032715) | 2.42627224 |
| 138 | positive regulation of cholesterol transport (GO:0032376) | 2.41891862 |
| 139 | positive regulation of sterol transport (GO:0032373) | 2.41891862 |
| 140 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.41479493 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41479493 |
| 142 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.41406139 |
| 143 | leukocyte cell-cell adhesion (GO:0007159) | 2.40083942 |
| 144 | mannose metabolic process (GO:0006013) | 2.38174840 |
| 145 | leukocyte degranulation (GO:0043299) | 2.36043553 |
| 146 | regulation of mast cell activation (GO:0033003) | 2.35908571 |
| 147 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.34662060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.77753542 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.95159128 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.86125341 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62069238 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.52678776 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.44593833 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.25664948 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00149263 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84876374 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77466498 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75080132 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.70633884 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62999064 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59004966 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.53099356 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.44502126 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38408458 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.23070094 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20160673 |
| 20 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18784671 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18202355 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04779080 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98533254 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92693152 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90947844 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.85868147 |
| 27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.67078481 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66213090 |
| 29 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.65689859 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63143458 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61499544 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61468588 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.60945330 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.57435688 |
| 35 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.54732910 |
| 36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53358336 |
| 37 | * MYB_26560356_Chip-Seq_TH2_Human | 1.52981610 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.48683866 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47968726 |
| 40 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46285233 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43668920 |
| 42 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.42879498 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39097294 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37256761 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31796976 |
| 46 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30206266 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30098014 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25179589 |
| 49 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23880113 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23651417 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22892348 |
| 52 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21608816 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19252732 |
| 54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17057500 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16467447 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16410904 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15275357 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15086922 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13995525 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12890661 |
| 61 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12695844 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10522134 |
| 63 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.10312993 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09773028 |
| 65 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.08712529 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07632409 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07405147 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.05931117 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04467034 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04245464 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04195544 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.02878012 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02352494 |
| 74 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01836082 |
| 75 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.00681255 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00638666 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99506896 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98501251 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98134264 |
| 80 | * MAF_26560356_Chip-Seq_TH2_Human | 0.95814326 |
| 81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94258358 |
| 82 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94137003 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93680005 |
| 84 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91778501 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90996648 |
| 86 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.90758090 |
| 87 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90322452 |
| 88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89939669 |
| 89 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89933197 |
| 90 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89270959 |
| 91 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89179986 |
| 92 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87735134 |
| 93 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87229840 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86887536 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84643033 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83320045 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83022589 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82502972 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82479425 |
| 100 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81822976 |
| 101 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.81289315 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80754675 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80443578 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79587999 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.79114469 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78390209 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78150479 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77794223 |
| 109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77318067 |
| 110 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76893199 |
| 111 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.76664548 |
| 112 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.76478450 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76087878 |
| 114 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.75799412 |
| 115 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75549146 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.75031769 |
| 117 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74630171 |
| 118 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.73787646 |
| 119 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72899598 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72474040 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.72326720 |
| 122 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.70295991 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70023471 |
| 124 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.69832614 |
| 125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.69407182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000569_abnormal_digit_pigmentation | 4.95078747 |
| 2 | MP0004510_myositis | 3.81353712 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.41552292 |
| 4 | * MP0001835_abnormal_antigen_presentation | 3.01769084 |
| 5 | MP0009278_abnormal_bone_marrow | 2.91008088 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.81015299 |
| 7 | MP0003436_decreased_susceptibility_to | 2.68615538 |
| 8 | MP0003303_peritoneal_inflammation | 2.65253845 |
| 9 | * MP0002419_abnormal_innate_immunity | 2.65167175 |
| 10 | * MP0001800_abnormal_humoral_immune | 2.62970849 |
| 11 | MP0005387_immune_system_phenotype | 2.51273220 |
| 12 | MP0001790_abnormal_immune_system | 2.51273220 |
| 13 | MP0000685_abnormal_immune_system | 2.47195351 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.34620133 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.19250938 |
| 16 | * MP0002723_abnormal_immune_serum | 2.16827315 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.13581771 |
| 18 | * MP0005174_abnormal_tail_pigmentation | 2.13460498 |
| 19 | * MP0003172_abnormal_lysosome_physiology | 2.09684099 |
| 20 | MP0004947_skin_inflammation | 2.07313967 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.06914336 |
| 22 | * MP0001819_abnormal_immune_cell | 2.06381783 |
| 23 | * MP0005464_abnormal_platelet_physiology | 2.04452125 |
| 24 | MP0005671_abnormal_response_to | 1.99299297 |
| 25 | * MP0000371_diluted_coat_color | 1.94072356 |
| 26 | MP0003828_pulmonary_edema | 1.92280491 |
| 27 | * MP0005025_abnormal_response_to | 1.91114990 |
| 28 | MP0004883_abnormal_blood_vessel | 1.90062403 |
| 29 | * MP0004381_abnormal_hair_follicle | 1.82799750 |
| 30 | MP0001873_stomach_inflammation | 1.79170159 |
| 31 | * MP0005058_abnormal_lysosome_morphology | 1.76157809 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.74262109 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.74262109 |
| 34 | * MP0002398_abnormal_bone_marrow | 1.69677253 |
| 35 | MP0009785_altered_susceptibility_to | 1.68435155 |
| 36 | MP0005451_abnormal_body_composition | 1.68021144 |
| 37 | MP0008057_abnormal_DNA_replication | 1.65552990 |
| 38 | MP0002928_abnormal_bile_duct | 1.65354623 |
| 39 | * MP0000716_abnormal_immune_system | 1.60966209 |
| 40 | * MP0002166_altered_tumor_susceptibility | 1.60953653 |
| 41 | * MP0000015_abnormal_ear_pigmentation | 1.59967546 |
| 42 | MP0010307_abnormal_tumor_latency | 1.59664110 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.57374081 |
| 44 | MP0003787_abnormal_imprinting | 1.56989148 |
| 45 | MP0002405_respiratory_system_inflammati | 1.53100216 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.50809835 |
| 47 | * MP0000689_abnormal_spleen_morphology | 1.48299361 |
| 48 | * MP0005075_abnormal_melanosome_morpholog | 1.46615224 |
| 49 | MP0005164_abnormal_response_to | 1.41948076 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.41547348 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.41304868 |
| 52 | MP0000604_amyloidosis | 1.40142304 |
| 53 | MP0002254_reproductive_system_inflammat | 1.38238121 |
| 54 | MP0003045_fibrosis | 1.36281680 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.34441881 |
| 56 | MP0003091_abnormal_cell_migration | 1.33798826 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.31651077 |
| 58 | MP0006082_CNS_inflammation | 1.29978292 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.28882652 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.28050138 |
| 61 | * MP0002722_abnormal_immune_system | 1.27678114 |
| 62 | MP0003448_altered_tumor_morphology | 1.26702331 |
| 63 | MP0001853_heart_inflammation | 1.26639382 |
| 64 | MP0008260_abnormal_autophagy | 1.26610098 |
| 65 | * MP0002429_abnormal_blood_cell | 1.26368703 |
| 66 | * MP0002006_tumorigenesis | 1.22101191 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21882235 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.19303817 |
| 69 | MP0002132_abnormal_respiratory_system | 1.18904423 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.17586594 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.17212065 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.14889585 |
| 73 | MP0004484_altered_response_of | 1.14721645 |
| 74 | * MP0000703_abnormal_thymus_morphology | 1.12648700 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.10155220 |
| 76 | MP0008877_abnormal_DNA_methylation | 1.07312392 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.06809464 |
| 78 | MP0001851_eye_inflammation | 1.05118420 |
| 79 | MP0008469_abnormal_protein_level | 1.04847157 |
| 80 | MP0002009_preneoplasia | 1.04240392 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.03257015 |
| 82 | MP0009697_abnormal_copulation | 1.02285058 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.00818028 |
| 84 | MP0005409_darkened_coat_color | 0.95831695 |
| 85 | MP0009764_decreased_sensitivity_to | 0.94519198 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.93973190 |
| 87 | MP0003690_abnormal_glial_cell | 0.93919541 |
| 88 | * MP0002095_abnormal_skin_pigmentation | 0.92374368 |
| 89 | MP0005310_abnormal_salivary_gland | 0.92012514 |
| 90 | MP0002933_joint_inflammation | 0.91929844 |
| 91 | MP0004130_abnormal_muscle_cell | 0.91595773 |
| 92 | * MP0002075_abnormal_coat/hair_pigmentati | 0.91567811 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.91505127 |
| 94 | MP0009763_increased_sensitivity_to | 0.91155295 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.90675524 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.88013886 |
| 97 | MP0005621_abnormal_cell_physiology | 0.85588028 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.82486975 |
| 99 | MP0003075_altered_response_to | 0.81034892 |
| 100 | MP0003279_aneurysm | 0.79950827 |
| 101 | * MP0000858_altered_metastatic_potential | 0.78945226 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.78844744 |
| 103 | MP0003724_increased_susceptibility_to | 0.78343585 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.77828758 |
| 105 | MP0000609_abnormal_liver_physiology | 0.77706815 |
| 106 | MP0003866_abnormal_defecation | 0.76859143 |
| 107 | MP0005166_decreased_susceptibility_to | 0.76512055 |
| 108 | MP0003252_abnormal_bile_duct | 0.76013354 |
| 109 | MP0009840_abnormal_foam_cell | 0.75373303 |
| 110 | MP0005171_absent_coat_pigmentation | 0.74146329 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.72481786 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 0.68543848 |
| 113 | MP0000249_abnormal_blood_vessel | 0.68494770 |
| 114 | MP0002168_other_aberrant_phenotype | 0.67225137 |
| 115 | * MP0001186_pigmentation_phenotype | 0.67129543 |
| 116 | MP0001915_intracranial_hemorrhage | 0.66685727 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.66334360 |
| 118 | MP0005670_abnormal_white_adipose | 0.64616000 |
| 119 | MP0006054_spinal_hemorrhage | 0.62808753 |
| 120 | MP0001663_abnormal_digestive_system | 0.62743948 |
| 121 | MP0003329_amyloid_beta_deposits | 0.62636576 |
| 122 | MP0008874_decreased_physiological_sensi | 0.58157498 |
| 123 | MP0008004_abnormal_stomach_pH | 0.57288944 |
| 124 | * MP0002019_abnormal_tumor_incidence | 0.54486346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal infarctions (HP:0005244) | 4.33015153 |
| 2 | Abnormality of the fingertips (HP:0001211) | 4.23196655 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.17878746 |
| 4 | * Recurrent abscess formation (HP:0002722) | 4.11532591 |
| 5 | * Recurrent bacterial skin infections (HP:0005406) | 3.81415351 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 3.77663442 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.72400693 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63869427 |
| 9 | Keratoconjunctivitis (HP:0001096) | 3.53528973 |
| 10 | Stomatitis (HP:0010280) | 3.51410933 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.41622977 |
| 12 | Absent frontal sinuses (HP:0002688) | 3.32745215 |
| 13 | Chest pain (HP:0100749) | 3.31355453 |
| 14 | Encephalitis (HP:0002383) | 3.27928211 |
| 15 | Abnormality of T cells (HP:0002843) | 3.27895551 |
| 16 | Recurrent viral infections (HP:0004429) | 3.26052120 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.24253481 |
| 18 | Hemoptysis (HP:0002105) | 3.16692152 |
| 19 | Peritonitis (HP:0002586) | 3.14719827 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.10936799 |
| 21 | Colitis (HP:0002583) | 2.99899637 |
| 22 | Abnormality of macrophages (HP:0004311) | 2.96327298 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95156244 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95156244 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93879219 |
| 26 | Urticaria (HP:0001025) | 2.81893080 |
| 27 | * Recurrent skin infections (HP:0001581) | 2.76073231 |
| 28 | * Gingival bleeding (HP:0000225) | 2.71728239 |
| 29 | Subacute progressive viral hepatitis (HP:0006572) | 2.71488526 |
| 30 | * Gingivitis (HP:0000230) | 2.68614575 |
| 31 | Pulmonary embolism (HP:0002204) | 2.59500369 |
| 32 | Eosinophilia (HP:0001880) | 2.57859247 |
| 33 | Vasculitis (HP:0002633) | 2.56819299 |
| 34 | Hematochezia (HP:0002573) | 2.56181012 |
| 35 | Prostate neoplasm (HP:0100787) | 2.52569180 |
| 36 | Thick nail (HP:0001805) | 2.51322534 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50992593 |
| 38 | Gangrene (HP:0100758) | 2.50433291 |
| 39 | Thyroiditis (HP:0100646) | 2.50037396 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.49617680 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48411210 |
| 42 | Myositis (HP:0100614) | 2.47474158 |
| 43 | Osteomyelitis (HP:0002754) | 2.46748044 |
| 44 | Leukocytosis (HP:0001974) | 2.46672972 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.44521710 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.43618900 |
| 47 | * Epistaxis (HP:0000421) | 2.41060848 |
| 48 | Viral hepatitis (HP:0006562) | 2.40144927 |
| 49 | Submucous cleft hard palate (HP:0000176) | 2.39650490 |
| 50 | Myocardial infarction (HP:0001658) | 2.35816684 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.35132774 |
| 52 | Optic neuritis (HP:0100653) | 2.35132774 |
| 53 | Anorexia (HP:0002039) | 2.33740425 |
| 54 | Narrow palate (HP:0000189) | 2.32592153 |
| 55 | T lymphocytopenia (HP:0005403) | 2.32344784 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.30959818 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.30933004 |
| 58 | Premature loss of primary teeth (HP:0006323) | 2.30357998 |
| 59 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.29387860 |
| 60 | Urethral obstruction (HP:0000796) | 2.26902927 |
| 61 | Increased IgE level (HP:0003212) | 2.26813121 |
| 62 | Acute hepatic failure (HP:0006554) | 2.26004781 |
| 63 | Episodic fever (HP:0001954) | 2.25577783 |
| 64 | Macroorchidism (HP:0000053) | 2.23974715 |
| 65 | Postural instability (HP:0002172) | 2.23840430 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.21791739 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.20980854 |
| 68 | Amyloidosis (HP:0011034) | 2.20594012 |
| 69 | Distal lower limb amyotrophy (HP:0008944) | 2.18399958 |
| 70 | Heterotopia (HP:0002282) | 2.17996916 |
| 71 | Abnormality of the frontal sinuses (HP:0002687) | 2.17654072 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.17316507 |
| 73 | Orchitis (HP:0100796) | 2.14823558 |
| 74 | Cellulitis (HP:0100658) | 2.14600784 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.13995473 |
| 76 | Meningitis (HP:0001287) | 2.13969366 |
| 77 | Large earlobe (HP:0009748) | 2.10837354 |
| 78 | Papillary thyroid carcinoma (HP:0002895) | 2.10789027 |
| 79 | Fatigue (HP:0012378) | 2.10352452 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.09336368 |
| 81 | Long toe (HP:0010511) | 2.07648422 |
| 82 | Granulocytopenia (HP:0001913) | 2.06904802 |
| 83 | Joint hemorrhage (HP:0005261) | 2.06604536 |
| 84 | * Periodontitis (HP:0000704) | 2.06158333 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.05808823 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.05425134 |
| 87 | Obstructive lung disease (HP:0006536) | 2.04942763 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04942763 |
| 89 | Pustule (HP:0200039) | 2.04652607 |
| 90 | Arterial thrombosis (HP:0004420) | 2.04045046 |
| 91 | Abnormality of the peritoneum (HP:0002585) | 2.03576537 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 2.03392305 |
| 93 | Sepsis (HP:0100806) | 2.03291273 |
| 94 | Keratitis (HP:0000491) | 2.02987157 |
| 95 | Hypochromic anemia (HP:0001931) | 2.02272071 |
| 96 | Progressive hearing impairment (HP:0001730) | 2.02206611 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.00070568 |
| 98 | Amaurosis fugax (HP:0100576) | 1.99967877 |
| 99 | * Ocular albinism (HP:0001107) | 1.98931526 |
| 100 | Restrictive lung disease (HP:0002091) | 1.98714216 |
| 101 | Microcytic anemia (HP:0001935) | 1.98695586 |
| 102 | Frequent falls (HP:0002359) | 1.96550529 |
| 103 | Abnormality of the thoracic spine (HP:0100711) | 1.95414755 |
| 104 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95388200 |
| 105 | Vertigo (HP:0002321) | 1.94497336 |
| 106 | Resting tremor (HP:0002322) | 1.94096636 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 1.93879540 |
| 108 | Upper motor neuron abnormality (HP:0002127) | 1.93791448 |
| 109 | Generalized hypopigmentation of hair (HP:0011358) | 1.93046952 |
| 110 | Progressive sensorineural hearing impairment (HP:0000408) | 1.91889018 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91883200 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 1.91308311 |
| 113 | Papilledema (HP:0001085) | 1.90863052 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.90243721 |
| 115 | Glomerulopathy (HP:0100820) | 1.89865711 |
| 116 | Conjunctival telangiectasia (HP:0000524) | 1.88581428 |
| 117 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.88391704 |
| 118 | Visual hallucinations (HP:0002367) | 1.87636717 |
| 119 | Lower limb amyotrophy (HP:0007210) | 1.87234295 |
| 120 | Lymphopenia (HP:0001888) | 1.86729988 |
| 121 | Thrombophlebitis (HP:0004418) | 1.86646670 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86558858 |
| 123 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86558858 |
| 124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86558858 |
| 125 | Cheilitis (HP:0100825) | 1.86107812 |
| 126 | Disinhibition (HP:0000734) | 1.85198819 |
| 127 | Coarse hair (HP:0002208) | 1.83844152 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.83680866 |
| 129 | Abnormality of vision evoked potentials (HP:0000649) | 1.83070616 |
| 130 | Abnormality of the columella (HP:0009929) | 1.82738724 |
| 131 | Widely spaced teeth (HP:0000687) | 1.82718899 |
| 132 | Syringomyelia (HP:0003396) | 1.81366471 |
| 133 | Spinal cord lesions (HP:0100561) | 1.81366471 |
| 134 | Increased CSF protein (HP:0002922) | 1.80619160 |
| 135 | Inappropriate behavior (HP:0000719) | 1.80353361 |
| 136 | Pathologic fracture (HP:0002756) | 1.79881884 |
| 137 | Hemiplegia (HP:0002301) | 1.79358327 |
| 138 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.79052023 |
| 139 | Lip pit (HP:0100267) | 1.78945262 |
| 140 | Volvulus (HP:0002580) | 1.78825552 |
| 141 | Mitral stenosis (HP:0001718) | 1.78141754 |
| 142 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77833481 |
| 143 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77833481 |
| 144 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77833481 |
| 145 | Abnormal platelet volume (HP:0011876) | 1.77723757 |
| 146 | Polyneuropathy (HP:0001271) | 1.77402579 |
| 147 | Global brain atrophy (HP:0002283) | 1.77266411 |
| 148 | Impaired platelet aggregation (HP:0003540) | 1.77048837 |
| 149 | Abnormal platelet function (HP:0011869) | 1.77048837 |
| 150 | Albinism (HP:0001022) | 1.76899460 |
| 151 | Joint swelling (HP:0001386) | 1.75987884 |
| 152 | Chronic diarrhea (HP:0002028) | 1.75322467 |
| 153 | Increased IgM level (HP:0003496) | 1.73828155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 3.37012944 |
| 2 | RIPK4 | 3.33326263 |
| 3 | MAP3K14 | 3.23375528 |
| 4 | TAOK3 | 3.04455801 |
| 5 | CAMK1D | 2.55686102 |
| 6 | CAMK1G | 2.55233631 |
| 7 | MAP4K1 | 2.51218305 |
| 8 | TYK2 | 2.41838612 |
| 9 | SIK2 | 2.40634498 |
| 10 | CDK12 | 2.36572757 |
| 11 | IRAK4 | 2.34897176 |
| 12 | KIT | 2.26406048 |
| 13 | JAK1 | 2.20356185 |
| 14 | IRAK3 | 1.94575774 |
| 15 | IKBKE | 1.82466105 |
| 16 | JAK3 | 1.75565185 |
| 17 | PIK3CG | 1.75406404 |
| 18 | FES | 1.73268487 |
| 19 | TTN | 1.72496652 |
| 20 | TXK | 1.71767240 |
| 21 | MAP3K2 | 1.67763608 |
| 22 | BMPR2 | 1.66883609 |
| 23 | SGK2 | 1.64509466 |
| 24 | HCK | 1.61221292 |
| 25 | SGK3 | 1.61020049 |
| 26 | BRD4 | 1.60589199 |
| 27 | DAPK2 | 1.57267357 |
| 28 | IKBKB | 1.53646901 |
| 29 | CSF1R | 1.52926627 |
| 30 | IRAK1 | 1.41546578 |
| 31 | PTK2B | 1.37884605 |
| 32 | CAMKK2 | 1.35572756 |
| 33 | PTK6 | 1.35298355 |
| 34 | TBK1 | 1.34878598 |
| 35 | MAP3K3 | 1.31779205 |
| 36 | RIPK1 | 1.28496314 |
| 37 | CHUK | 1.26508484 |
| 38 | SYK | 1.24927841 |
| 39 | EPHB1 | 1.22683629 |
| 40 | FGFR3 | 1.20379428 |
| 41 | ZAP70 | 1.19577300 |
| 42 | CSK | 1.14811710 |
| 43 | TNK2 | 1.14719936 |
| 44 | CDK6 | 1.13666903 |
| 45 | IRAK2 | 1.10944320 |
| 46 | MAP3K1 | 1.08930573 |
| 47 | ITK | 1.03064839 |
| 48 | KSR2 | 1.01507052 |
| 49 | KSR1 | 0.98628241 |
| 50 | LCK | 0.97842011 |
| 51 | MARK3 | 0.94354581 |
| 52 | SGK1 | 0.92820245 |
| 53 | NLK | 0.92333084 |
| 54 | JAK2 | 0.91687917 |
| 55 | MATK | 0.91672755 |
| 56 | PRKAA2 | 0.90873113 |
| 57 | BTK | 0.88252451 |
| 58 | INSRR | 0.88167055 |
| 59 | TEC | 0.87327677 |
| 60 | TAOK1 | 0.86905387 |
| 61 | MAP2K3 | 0.84343689 |
| 62 | SGK223 | 0.81478322 |
| 63 | SGK494 | 0.81478322 |
| 64 | TRPM7 | 0.79817758 |
| 65 | PDK1 | 0.79746825 |
| 66 | GRK5 | 0.79162290 |
| 67 | LRRK2 | 0.79039814 |
| 68 | FGFR4 | 0.78110800 |
| 69 | NEK9 | 0.77859438 |
| 70 | PDGFRB | 0.76104792 |
| 71 | CAMKK1 | 0.75457457 |
| 72 | FGR | 0.73904840 |
| 73 | MAP3K7 | 0.71904248 |
| 74 | RPS6KA2 | 0.71527969 |
| 75 | MAPK7 | 0.70247538 |
| 76 | EPHA3 | 0.70224298 |
| 77 | HIPK2 | 0.68355710 |
| 78 | PRKCH | 0.67936923 |
| 79 | MAP3K10 | 0.67872499 |
| 80 | RAF1 | 0.67522507 |
| 81 | WNK1 | 0.67037011 |
| 82 | PDPK1 | 0.65861889 |
| 83 | STK38 | 0.65839167 |
| 84 | MAP3K11 | 0.65176319 |
| 85 | GRK6 | 0.64784010 |
| 86 | ACVR1B | 0.64663978 |
| 87 | MAP3K5 | 0.64417958 |
| 88 | CDK9 | 0.64334468 |
| 89 | ERBB2 | 0.63693378 |
| 90 | PAK3 | 0.63284318 |
| 91 | SIK1 | 0.62631697 |
| 92 | MAP3K9 | 0.60801942 |
| 93 | LYN | 0.60643290 |
| 94 | EGFR | 0.60572969 |
| 95 | MTOR | 0.59776694 |
| 96 | MAP2K4 | 0.59452415 |
| 97 | PRPF4B | 0.59381671 |
| 98 | ERN1 | 0.59174822 |
| 99 | MELK | 0.58157150 |
| 100 | PKN1 | 0.57739287 |
| 101 | RET | 0.57219506 |
| 102 | CDK19 | 0.56557162 |
| 103 | MAPK12 | 0.55306053 |
| 104 | BLK | 0.54764848 |
| 105 | CAMK4 | 0.54433932 |
| 106 | NEK6 | 0.52070104 |
| 107 | DYRK1A | 0.51616769 |
| 108 | PIM1 | 0.51470343 |
| 109 | STK10 | 0.50252001 |
| 110 | DAPK1 | 0.49976801 |
| 111 | ATR | 0.49928710 |
| 112 | YES1 | 0.49718049 |
| 113 | NUAK1 | 0.49610752 |
| 114 | FYN | 0.48952174 |
| 115 | SCYL2 | 0.48630395 |
| 116 | MARK2 | 0.48110589 |
| 117 | MAP2K6 | 0.47511077 |
| 118 | SIK3 | 0.46969435 |
| 119 | PRKCQ | 0.46775848 |
| 120 | STK11 | 0.46515599 |
| 121 | ABL1 | 0.45970421 |
| 122 | FRK | 0.45452269 |
| 123 | FLT3 | 0.44614551 |
| 124 | TGFBR2 | 0.44555095 |
| 125 | RPS6KA6 | 0.43326200 |
| 126 | STK4 | 0.43107085 |
| 127 | RPS6KL1 | 0.42690731 |
| 128 | RPS6KC1 | 0.42690731 |
| 129 | RPS6KA4 | 0.42276192 |
| 130 | MAPK10 | 0.41660607 |
| 131 | MAP3K6 | 0.40779377 |
| 132 | PLK2 | 0.40445173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39532002 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29660978 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25754573 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21348783 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06148011 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.01718610 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.79639051 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73149047 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72230028 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62831735 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61030863 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.58570821 |
| 13 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.58330052 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56932825 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.52769992 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.51277824 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46833012 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45959206 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41748138 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40109328 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39360222 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38876986 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35508383 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.34323692 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33905978 |
| 26 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.26999406 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26103867 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21661961 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20069513 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20065185 |
| 31 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17454242 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15207784 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11611606 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.11303980 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.09256789 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.08872654 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.07617912 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07171957 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.05772128 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03669592 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03342677 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02924087 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02102047 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.01245063 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01188538 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.01091844 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98222778 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.98063683 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.98012495 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.96609801 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95004851 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93860497 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92804388 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86091973 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85972349 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.85134812 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83800336 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82476650 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79029543 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78687080 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78491110 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78042984 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77489822 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77350035 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76780303 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.76455689 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75531220 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75040109 |
| 69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74370926 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73944210 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73513130 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72049648 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71785027 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71444405 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70293636 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70204515 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.69618413 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69488048 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68848674 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68637550 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68015128 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67241853 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67182546 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66375627 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64770322 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64097284 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.63695377 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62433567 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61535451 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61301558 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61284121 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59958199 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.59821861 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59688484 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58857258 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57576215 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56643274 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54827287 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53695762 |
| 100 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53112260 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.51883101 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51817300 |
| 103 | Morphine addiction_Homo sapiens_hsa05032 | 0.51715747 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51400842 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50884149 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50495122 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.50491755 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50425630 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49519461 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49278802 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.49180328 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48342216 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47875704 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47842520 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47631868 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47333272 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46298409 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.45868751 |

